Profile change history

What changed for Terlipressin?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Terlipressin identity.

63Total events
63Record additions
0Version changes
15Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 63 connected records →

Showing the latest 63 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00089570

PeptideScanner retained ClinicalTrials.gov record NCT00089570 at 2026-11-15T21:47:40.408Z. Its registry update date was 2017-10-27, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 27, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00115947

PeptideScanner retained ClinicalTrials.gov record NCT00115947 at 2026-11-15T21:47:40.408Z. Its registry update date was 2006-03-09, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 9, 2006
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00369694

PeptideScanner retained ClinicalTrials.gov record NCT00369694 at 2026-11-15T21:47:40.408Z. Its registry update date was 2008-09-25, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
September 25, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00370253

PeptideScanner retained ClinicalTrials.gov record NCT00370253 at 2026-11-15T21:47:40.408Z. Its registry update date was 2008-04-11, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 11, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00628160

PeptideScanner retained ClinicalTrials.gov record NCT00628160 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-02-24, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 24, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00986817

PeptideScanner retained ClinicalTrials.gov record NCT00986817 at 2026-11-15T21:47:40.408Z. Its registry update date was 2015-06-15, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
June 15, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01143246

PeptideScanner retained ClinicalTrials.gov record NCT01143246 at 2026-11-15T21:47:40.408Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
November 29, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01373606

PeptideScanner retained ClinicalTrials.gov record NCT01373606 at 2026-11-15T21:47:40.408Z. Its registry update date was 2012-02-14, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 14, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01637454

PeptideScanner retained ClinicalTrials.gov record NCT01637454 at 2026-11-15T21:47:40.408Z. Its registry update date was 2012-07-11, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 11, 2012
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02059460

PeptideScanner retained ClinicalTrials.gov record NCT02059460 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 15, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02588716

PeptideScanner retained ClinicalTrials.gov record NCT02588716 at 2026-11-15T21:47:40.408Z. Its registry update date was 2017-12-27, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 27, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02718599

PeptideScanner retained ClinicalTrials.gov record NCT02718599 at 2026-11-15T21:47:40.408Z. Its registry update date was 2017-12-19, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 19, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02757703

PeptideScanner retained ClinicalTrials.gov record NCT02757703 at 2026-11-15T21:47:40.408Z. Its registry update date was 2016-05-03, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 3, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02770716

PeptideScanner retained ClinicalTrials.gov record NCT02770716 at 2026-11-15T21:47:40.408Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
November 29, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03107091

PeptideScanner retained ClinicalTrials.gov record NCT03107091 at 2026-11-15T21:47:40.408Z. Its registry update date was 2021-07-13, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 13, 2021
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03395574

PeptideScanner retained ClinicalTrials.gov record NCT03395574 at 2026-11-15T21:47:40.408Z. Its registry update date was 2018-12-24, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 24, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03572088

PeptideScanner retained ClinicalTrials.gov record NCT03572088 at 2026-11-15T21:47:40.408Z. Its registry update date was 2023-05-22, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 22, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03584087

PeptideScanner retained ClinicalTrials.gov record NCT03584087 at 2026-11-15T21:47:40.408Z. Its registry update date was 2019-12-16, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
December 16, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03822091

PeptideScanner retained ClinicalTrials.gov record NCT03822091 at 2026-11-15T21:47:40.408Z. Its registry update date was 2023-05-09, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
May 9, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04358016

PeptideScanner retained ClinicalTrials.gov record NCT04358016 at 2026-11-15T21:47:40.408Z. Its registry update date was 2020-04-22, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 22, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04416282

PeptideScanner retained ClinicalTrials.gov record NCT04416282 at 2026-11-15T21:47:40.408Z. Its registry update date was 2023-04-06, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 6, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04460560

PeptideScanner retained ClinicalTrials.gov record NCT04460560 at 2026-11-15T21:47:40.408Z. Its registry update date was 2024-10-09, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 9, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04961528

PeptideScanner retained ClinicalTrials.gov record NCT04961528 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-04-23, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 23, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05242783

PeptideScanner retained ClinicalTrials.gov record NCT05242783 at 2026-11-15T21:47:40.408Z. Its registry update date was 2024-06-25, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
June 25, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06108362

PeptideScanner retained ClinicalTrials.gov record NCT06108362 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
October 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06256432

PeptideScanner retained ClinicalTrials.gov record NCT06256432 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-04-13, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06855758

PeptideScanner retained ClinicalTrials.gov record NCT06855758 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 13, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07252401

PeptideScanner retained ClinicalTrials.gov record NCT07252401 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
August 27, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07304466

PeptideScanner retained ClinicalTrials.gov record NCT07304466 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-04-29, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
April 29, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07719933

PeptideScanner retained ClinicalTrials.gov record NCT07719933 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 28, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 2020-14719

The Federal Register published notice 2020-14719, attributed to FDA and its parent HHS department, on 2020-07-08. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
July 8, 2020
Evidence lane
Regulatory
Record added

Federal Register notice 2024-03300

The Federal Register published notice 2024-03300, attributed to FDA and its parent HHS department, on 2024-02-16. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Terlipressin.

PeptideScanner change date
November 15, 2026
Cited source date
February 16, 2024
Evidence lane
Regulatory
Record added

Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.

PubMed lists PMID 18683478 in Best practice & research. Clinical anaesthesiology as Journal Article, Review, with publication-date metadata of 2008-06 (month precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 11, 2019
Evidence lane
Literature metadata
Record added

[Meta-analysis of terlipressin in treatment of hepatorenal syndrome: an update].

PubMed lists PMID 19950571 in Zhonghua yi xue za zhi as Journal Article, Meta-Analysis, with publication-date metadata of 2009-07-28 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.

PubMed lists PMID 20306131 in International urology and nephrology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2010-03-20 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 26, 2025
Evidence lane
Literature metadata
Record added

The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.

PubMed lists PMID 22075285 in European journal of internal medicine as Clinical Trial, Journal Article, Multicenter Study, with publication-date metadata of 2011-08-02 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study.

PubMed lists PMID 22322237 in Journal of hepatology as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2012-02-06 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 19, 2024
Evidence lane
Literature metadata
Record added

Terlipressin for hepatorenal syndrome.

PubMed lists PMID 22972083 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2012-09-12 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 26, 2025
Evidence lane
Literature metadata
Record added

Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.

PubMed lists PMID 23601499 in Liver international : official journal of the International Association for the Study of the Liver as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2013-04-21 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 28, 2026
Evidence lane
Literature metadata
Record added

Noradrenaline or terlipressin for hepatorenal syndrome?

PubMed lists PMID 26334297 in Medwave as Comparative Study, Journal Article, Meta-Analysis, with publication-date metadata of 2015-08-27 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation.

PubMed lists PMID 26649801 in European journal of gastroenterology & hepatology as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2016-03 (month precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.

PubMed lists PMID 27633962 in Liver international : official journal of the International Association for the Study of the Liver as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2016-10-20 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Comparison of 12-Hour with 72-Hour Terlipressin Therapy for Bleeding Esophageal Varices.

PubMed lists PMID 28689520 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017-06 (month precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.

PubMed lists PMID 29943803 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2017-06-14 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 23, 2025
Evidence lane
Literature metadata
Record added

Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.

PubMed lists PMID 30474439 in Current medical research and opinion as Journal Article, Review, with publication-date metadata of 2019-01-04 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 24, 2020
Evidence lane
Literature metadata
Record added

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis.

PubMed lists PMID 31920672 in Frontiers in pharmacology as Systematic Review, Journal Article, with publication-date metadata of 2019-12-23 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 30, 2020
Evidence lane
Literature metadata
Record added

[Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].

PubMed lists PMID 31941255 in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology as Journal Article, Review, with publication-date metadata of 2019-12-20 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation.

PubMed lists PMID 32574418 in Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society as Journal Article, Review, with publication-date metadata of 2020-08-09 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 21, 2024
Evidence lane
Literature metadata
Record added

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.

PubMed lists PMID 32676484 in Canadian journal of gastroenterology & hepatology as Journal Article, Systematic Review, with publication-date metadata of 2020-06-22 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 6, 2021
Evidence lane
Literature metadata
Record added

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.

PubMed lists PMID 33657294 in The New England journal of medicine as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-03-04 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 18, 2026
Evidence lane
Literature metadata
Record added

RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY.

PubMed lists PMID 35442343 in Arquivos de gastroenterologia as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2022 Jan-Mar (source-text precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 22, 2022
Evidence lane
Literature metadata
Record added

Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.

PubMed lists PMID 35838488 in Liver international : official journal of the International Association for the Study of the Liver as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-08-03 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 28, 2025
Evidence lane
Literature metadata
Record added

TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW.

PubMed lists PMID 37548701 in Shock (Augusta, Ga.) as Systematic Review, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-08-07 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 24, 2024
Evidence lane
Literature metadata
Record added

Terlipressin for hepatorenal syndrome.

PubMed lists PMID 38353275 in Current opinion in gastroenterology as Review, Journal Article, with publication-date metadata of 2024-03-07 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 29, 2025
Evidence lane
Literature metadata
Record added

From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.

PubMed lists PMID 38353565 in Hepatology (Baltimore, Md.) as Journal Article, Review, Research Support, N.I.H., Extramural, with publication-date metadata of 2024-02-14 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 26, 2026
Evidence lane
Literature metadata
Record added

A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage.

PubMed lists PMID 38526204 in The American journal of gastroenterology as Journal Article, Randomized Controlled Trial, Equivalence Trial, Comparative Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-05-25 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 9, 2026
Evidence lane
Literature metadata
Record added

Formulary Drug Reviews: Terlipressin.

PubMed lists PMID 38560548 in Hospital pharmacy as Journal Article, Review, with publication-date metadata of 2023-01-26 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2024
Evidence lane
Literature metadata
Record added

Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.

PubMed lists PMID 39295934 in Frontiers in pharmacology as Journal Article, Systematic Review, with publication-date metadata of 2024-09-04 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 20, 2024
Evidence lane
Literature metadata
Record added

The Application of Terlipressin in the Management of Ascites in Liver Cirrhosis: Current Status and Prospects.

PubMed lists PMID 39618221 in British journal of hospital medicine (London, England : 2005) as Journal Article, Review, with publication-date metadata of 2024-11-25 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 5, 2024
Evidence lane
Literature metadata
Record added

Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-on-Chronic Liver Failure.

PubMed lists PMID 41200852 in Liver international : official journal of the International Association for the Study of the Liver as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-12 (month precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 11, 2026
Evidence lane
Literature metadata
Record added

The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review.

PubMed lists PMID 41204083 in BMC anesthesiology as Journal Article, Case Reports, Review, with publication-date metadata of 2025-11-07 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 4, 2026
Evidence lane
Literature metadata
Record added

Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI).

PubMed lists PMID 41711944 in Pediatric nephrology (Berlin, Germany) as Journal Article, Review, with publication-date metadata of 2026-02-19 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 20, 2026
Evidence lane
Literature metadata